MARKETS
S&P 5007,744.1+0.33%
NASDAQ 10029,935.6-0.05%
DOW 3052,177.7+1.08%
NIKKEI 22565,563.9+1.77%
DAX25,382.6+0.33%
FTSE 10010,840.4+1.08%
Business News

Amodei Says the AI Industry 'Lied' About the Technology's Risks

Anthropic's Dario Amodei told CBS Sunday Morning the AI industry 'lied' about the technology's risks, one day after calling on frontier labs to slow down their research.

Gregory Nash 6 min read
Camera capturing an indoor interview scene, in focus with a blurred background.

Anthropic chief executive Dario Amodei said on CBS Sunday Morning that the artificial intelligence industry had 'lied' about the technology's risks, a day after he urged AI companies to slow down their frontier research.

Dario Amodei, the chief executive of Anthropic, told CBS Sunday Morning that the artificial intelligence industry has "lied" about the risks its technology carries. The accusation is unusual not because the criticism is new, but because of who is making it: Amodei runs one of the handful of laboratories building the frontier systems in question, and his company's commercial pitch has been built in large part on the claim that it takes those risks more seriously than its competitors do.

The remarks, first reported by Forbes, landed one day after Amodei publicly called on AI companies to slow down their frontier research. Taken together, the two statements amount to the most direct self-criticism yet from inside the small group of firms that set the pace for the entire sector.

A Call to Slow Down, Then an Accusation

The sequencing matters. A call to slow frontier research — the work at the leading edge of model capability, where each new system does things the previous one could not — is a statement about pace. The claim that the industry "lied" about risk is a statement about honesty. The first is a policy position that rivals can disagree with politely. The second is an allegation that the sector's public safety messaging has not matched what its builders privately understand.

That distinction is what gives the comment its weight. Frontier labs have spent years publishing safety frameworks, capability thresholds and responsible-scaling commitments. Those documents are the basis on which regulators in the United States, the United Kingdom and the European Union have so far largely chosen oversight-by-agreement rather than hard statutory limits. If the chief executive of one of those labs is willing to say on national television that the industry has not been straight about risk, the voluntary-commitment model becomes harder to defend as sufficient.

The Awkward Position Anthropic Occupies

Anthropic is not a bystander to frontier research. It is a participant, and a fast one. The company has shipped successive generations of its models into a market where enterprise customers choose vendors partly on capability and partly on release cadence. A call for the industry to slow down is therefore also a call for Anthropic to slow down — or an argument that coordinated restraint is the only kind that works, because unilateral restraint simply hands share to whoever declines to exercise it.

That is the collective-action problem at the centre of the AI safety debate, and it is why Amodei's language is likely to be read two ways. One reading is that a builder is warning the public about a danger he can see from the inside. The other is that a company differentiated on safety is reinforcing its differentiation. Both can be true simultaneously, and the market will not resolve the question quickly.

What Amodei did not do, on the facts available, is name individual companies or specify which claims he considers untrue. Without that specificity the accusation is broad, and broad accusations are easier for rivals to absorb without responding.

Why Public Markets Care About a Private Company's CEO

Anthropic is privately held, so there is no share price to register a reaction. The exposure sits elsewhere — in the listed cloud providers, chipmakers and software companies whose valuations now embed years of AI capital spending, and in the enterprise customers writing multi-year contracts on the assumption that frontier capability keeps improving on schedule.

Regulatory risk is the transmission channel. A slower frontier, whether self-imposed or legislated, changes the timing of the revenue that justifies today's infrastructure build. It does not necessarily change the destination, but the discount rate applied to AI-linked earnings is sensitive to timing in a way that few investors have had to test.

A slower frontier, whether self-imposed or legislated, changes the timing of the revenue that justifies today's infrastructure build.

Broad equity benchmarks, which carry heavy weightings in AI-exposed names, closed higher on the last session before the remarks. As of the last trade on Friday, 11 September 2026, the S&P 500 tracker (NYSEARCA: SPY) finished at $764.29, up 0.85% from a previous close of $757.83, with a day range of $763.60 to $766.38. The Nasdaq 100 tracker (NASDAQ: QQQ) closed at $714.88, a gain of 0.87% against a prior close of $708.69. The Dow tracker (NYSEARCA: DIA) ended at $525.79, up 0.97%. Those levels describe a market that was not, at that point, pricing any slowdown at the frontier.

What Would Make This More Than a Soundbite

Three things would turn the comment into something with consequences. The first is specificity: if Amodei or Anthropic sets out which risk claims they believe were misrepresented, and by whom, the statement moves from rhetoric to evidence that regulators can act on.

The second is a change in Anthropic's own behaviour. A slower release cadence, a deferred capability launch, or a published threshold the company declines to cross would demonstrate that the call to slow down applies to the speaker. Continued releases at the current pace would invite the obvious charge of inconsistency.

The third is whether rival laboratories respond at all. Silence is the cheapest option and the most likely one. A rebuttal, on the other hand, would drag the industry into an argument about what its safety documentation actually promised — an argument conducted in public, with lawmakers watching.

  • Whether Anthropic publishes specifics behind the "lied" characterisation.
  • Whether any frontier lab formally responds or adjusts its release schedule.
  • Whether legislators cite the remarks in support of binding rules rather than voluntary commitments.
  • Whether enterprise buyers alter contracting terms around model safety assurances.

For now the statement stands alone: an accusation of dishonesty about risk, made by someone with unusually good visibility into whether it is true, and unusually strong commercial reasons to say it.

Key facts

  • Who: Dario Amodei, chief executive of Anthropic
  • What he said: The AI industry 'lied' about the technology's risks
  • Where: CBS Sunday Morning, one day after calling for frontier labs to slow down
  • Market backdrop: QQQ closed at $714.88, +0.87%, as of last trade Fri 11 Sep 2026 20:00 GMT

Frequently asked questions

What exactly did Dario Amodei say?

Speaking on CBS Sunday Morning, Anthropic chief executive Dario Amodei said the artificial intelligence industry had 'lied' about the technology's risks. The remark came one day after he publicly called on AI companies to slow down their frontier research. He did not, on the facts reported, identify specific companies or itemise which claims he considered untrue.

What is frontier research in AI?

Frontier research refers to work at the leading edge of model capability — the training and release of systems that can do things previous generations could not. It is the area where safety concerns concentrate, because new capabilities are hardest to test in advance. Slowing frontier research means deferring the most advanced releases, not halting AI development generally.

Can investors buy shares in Anthropic?

No. Anthropic is a privately held company and has no publicly listed shares, so there is no ticker and no market price that reflects reaction to Amodei's comments. Investors seeking exposure to the AI build-out generally do so through listed cloud providers, semiconductor makers and software companies rather than through the frontier labs themselves.

Why would a company that builds AI call for the industry to slow down?

Amodei's position reflects a collective-action problem: a single lab that slows down unilaterally loses market share to those that do not, so restraint only works if it is coordinated. A company that has differentiated itself on safety also has commercial reasons to raise the issue publicly. Both motivations can operate at the same time.

How did equity markets close before the remarks?

As of the last trade on Friday, 11 September 2026 at 20:00 GMT, the S&P 500 tracker SPY closed at $764.29, up 0.85% from a prior close of $757.83. The Nasdaq 100 tracker QQQ finished at $714.88, up 0.87%, and the Dow tracker DIA closed at $525.79, up 0.97%. Markets were closed when the remarks aired.

What should observers watch next?

Three developments would give the statement consequence: whether Anthropic publishes specifics identifying which safety claims it considers misrepresented; whether Anthropic itself slows its own model release cadence; and whether rival frontier laboratories respond publicly. Legislative citation of the remarks in support of binding rules would be a fourth signal worth tracking.

Sources

Photo: Caique Araujo · Pexels Licence — source

Filed under Business News

More on Business News

See all →